Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RARE DISEASE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00004760
What this trial is testing

Study of Axial Mobility Exercises in Parkinson Disease

Who this might be right for
Parkinson Disease
Duke University 80
Not applicableStudy completedNCT00004274
What this trial is testing

Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

Who this might be right for
Turner's Syndrome
National Institute of Neurological Disorders and Stroke (NINDS) 260
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Not applicableEnrolling By InvitationNCT04703179
What this trial is testing

Rare and Undiagnosed Disease Research Biorepository

Who this might be right for
Undiagnosed DiseaseRare Diseases
Mayo Clinic 5,000
Not applicableStudy completedNCT00004479
What this trial is testing

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Who this might be right for
Syncope
Icahn School of Medicine at Mount Sinai
Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Not applicableLooking for participantsNCT06615206
What this trial is testing

A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)

Who this might be right for
MECP2 Duplication Syndrome
HuidaGene Therapeutics Co., Ltd. 6
Not applicableStudy completedNCT00004329
What this trial is testing

Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

Who this might be right for
Lipodystrophy
National Center for Research Resources (NCRR) 12
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableStudy completedNCT04725292
What this trial is testing

Rare Benign Lesion of Peins

Who this might be right for
Skin DiseasesPenile Diseases
Assiut University 1
Not applicableStudy completedNCT00004495
What this trial is testing

Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis

Who this might be right for
End Stage Renal DiseaseHyperhomocysteinemia
Georgetown University 84
Not applicableLooking for participantsNCT07786142
What this trial is testing

Transition of Care in Pediatric Rare Endocrine Disorders

Who this might be right for
Endocrine DisorderRare Disorders
Seoul National University Hospital 150
Not applicableStudy completedNCT01914172
What this trial is testing

Health Needs of Patients With Kallmann Syndrome

Who this might be right for
Kallmann SyndromeCongenital Hypogonadotropic HypogonadismIdiopathic Hypogonadotropic Hypogonadism
Centre Hospitalier Universitaire Vaudois 249
Testing effectiveness (Phase 2)Study completedNCT00004488
What this trial is testing

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

Who this might be right for
Gaucher's DiseaseOsteopenia
Children's Hospital Medical Center, Cincinnati 82
Not applicableUnknownNCT00004343
What this trial is testing

Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
National Center for Research Resources (NCRR) 40
Not applicableLooking for participantsNCT06213402
What this trial is testing

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Who this might be right for
Sickle Cell DiseaseThalassemiaHemolytic; Anemia, Hereditary, Due to Enzyme Disorder+6 more
Hospital Universitari Vall d'Hebron Research Institute 32,564
Not applicableStudy completedNCT04916977
What this trial is testing

Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Italia 200
Not applicableLooking for participantsNCT06595940
What this trial is testing

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

Who this might be right for
Undiagnosed DiseasesRare Diseases
National Human Genome Research Institute (NHGRI) 400
Large-scale testing (Phase 3)Study completedNCT00004650
What this trial is testing

Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

Who this might be right for
Osteoporosis
National Institute of Dental and Craniofacial Research (NIDCR) 150
Not applicableLooking for participantsNCT06676046
What this trial is testing

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

Who this might be right for
DyslipidemiaAtherosclerosis
National Heart, Lung, and Blood Institute (NHLBI) 1,500
Next Page